DEF 14AThe Ballot
Avalo Therapeutics, Inc. files DEF 14A
Filed Jun 27, 2024 · 2y ago · Accession 0001628280-24-030232
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- DEF 14A
- Filing date
- Jun 27, 2024
- Report date
- Aug 13, 2024
- Document
- def14a2024.htm
- Size
- 4.1 MB